[go: up one dir, main page]

AU6373094A - Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use - Google Patents

Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use

Info

Publication number
AU6373094A
AU6373094A AU63730/94A AU6373094A AU6373094A AU 6373094 A AU6373094 A AU 6373094A AU 63730/94 A AU63730/94 A AU 63730/94A AU 6373094 A AU6373094 A AU 6373094A AU 6373094 A AU6373094 A AU 6373094A
Authority
AU
Australia
Prior art keywords
enzyme
preparing
same
cosmetic composition
containing pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63730/94A
Inventor
Albert Scheller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6481081&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU6373094(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU6373094A publication Critical patent/AU6373094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22004—Bromelain (3.4.22.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63730/94A 1993-02-23 1994-02-22 Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use Abandoned AU6373094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4305460 1993-02-23
DE19934305460 DE4305460C2 (en) 1993-02-23 1993-02-23 Pharmaceutical or cosmetic preparation containing enzymes, process for their preparation and their use
PCT/DE1994/000208 WO1994019005A1 (en) 1993-02-23 1994-02-22 Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use

Publications (1)

Publication Number Publication Date
AU6373094A true AU6373094A (en) 1994-09-14

Family

ID=6481081

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63730/94A Abandoned AU6373094A (en) 1993-02-23 1994-02-22 Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use

Country Status (3)

Country Link
AU (1) AU6373094A (en)
DE (1) DE4305460C2 (en)
WO (1) WO1994019005A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947270B2 (en) 1992-05-22 2011-05-24 Arcimboldo Ab Removing dental plaque with krill enzymes
US6030612A (en) * 1994-11-22 2000-02-29 Phairson Medical Inc. Antimicrobial uses of multifunctional enzyme
US5945102A (en) * 1994-11-22 1999-08-31 Phairson Medical Inc. Crustacean and fish derived multifunctional enzyme
US5958406A (en) * 1994-11-22 1999-09-28 Phairson Medical Inc. Acne treatment with multifunctional enzyme
AU7656894A (en) * 1993-09-15 1995-04-03 Unilever Plc Skin care method and composition
US5560910A (en) * 1994-08-26 1996-10-01 Crandall; Wilson T. Topical anti-inflammatory composition and method
US6232088B1 (en) 1995-02-08 2001-05-15 Phairson Medical, Inc. Treatment and prevention of immune rejection reactions
FR2738743B1 (en) * 1995-09-19 1997-11-14 Oreal USE OF ASCORBIC ACID AS AN ACTIVE INGREDIENT FOR THE TREATMENT OF SEBORRHEA IN A COSMETIC AND / OR DERMATOLOGICAL COMPOSITION
DE19649097A1 (en) * 1996-11-27 1998-05-28 Beiersdorf Ag Pharmaceutical or cosmetic compositions comprising lipase(s)
DE19649098A1 (en) * 1996-11-27 1998-05-28 Beiersdorf Ag Pharmaceutical, cosmetic and other compositions containing protease
WO1998048775A1 (en) * 1997-02-12 1998-11-05 Johnson & Johnson Consumer Companies, Inc. Serine protease and topical retinoid compositions
DE19829789A1 (en) * 1998-07-03 2000-01-05 Beiersdorf Ag Against acne and inflamed comedones effective preparations containing serine proteases and one or more calcium salts
FR2778563A1 (en) * 1998-07-06 1999-11-19 Oreal METHOD FOR HYDRATING THE SKIN BY A LIPASE
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
CN100469391C (en) * 2004-06-10 2009-03-18 安米 Application of human lysozyme in preparation of medicine for treating acne
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
AT506095A1 (en) 2007-12-03 2009-06-15 Volopharm Gmbh USE OF PROTEASES
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
WO2009142515A1 (en) * 2008-05-19 2009-11-26 John Sylora Cosmetic composition containing pancreatic enzyme
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
PL2318035T3 (en) 2008-07-01 2019-10-31 Curemark Llc Methods and compositions for treating the symptoms of neurological disorders and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CN102300989B (en) * 2009-01-06 2015-12-09 柯尔朗恩有限责任公司 Compositions and methods for treating or preventing staphylococcus aureus infection and for eradicating or reducing staphylococcus aureus on surfaces
EP2373693A4 (en) 2009-01-06 2012-04-25 Curelon Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
WO2011050135A1 (en) 2009-10-21 2011-04-28 Curemark Llc Methods and compositions for the prevention and treatment of influenza
JP5976100B2 (en) 2011-04-21 2016-08-23 キュアマーク リミテッド ライアビリティ カンパニー Compounds for the treatment of neuropsychiatric disorders
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction
DE102018205244A1 (en) * 2018-04-09 2019-10-10 Beiersdorf Ag Cosmetic cleaning preparation containing amylase
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
IT202300013428A1 (en) 2023-06-28 2024-12-28 Bioseutica Bv NEW STABLE GEL FORMULATIONS FOR THE TREATMENT OF ACNE VULGARIS
EP4470525B1 (en) 2023-05-30 2025-11-26 Bioseutica B.V. New stable gel formulations for the treatment of acne vulgaris

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT282071B (en) * 1967-09-13 1970-06-10 Spofa Vereinigte Pharma Werke Cosmetic preparations for improving the appearance of the skin
IL36870A0 (en) * 1970-05-27 1971-07-28 Lysozyme Prod Inc Lysozyme containing compositions
US3860702A (en) * 1972-07-11 1975-01-14 Schuyler Dev Corp Anti-inflammatory compositions
US4355022A (en) * 1981-07-01 1982-10-19 Interon, Inc. Method of dental treatment
EP0133438A1 (en) * 1983-01-21 1985-02-27 Advanced Drug Technology Corporation Enzyme ointment
FR2556218B1 (en) * 1983-12-12 1986-11-14 Gerard Alain PHARMACEUTICAL PRODUCT FOR LOCAL APPLICATION CONSTITUTED BY THE ASSOCIATION OF AN ACTIVE MEDICINAL PRINCIPLE-ENZYMATIC AGENT
WO1988000043A1 (en) * 1986-07-07 1988-01-14 Den Mat Corporation Toothpaste
JP2700465B2 (en) * 1988-05-09 1998-01-21 関西酵素株式会社 Toiletries containing lysozyme chloride
JPH0615462B2 (en) * 1989-01-12 1994-03-02 レイコ 小阪 Hair composition
DK0456724T3 (en) * 1989-01-27 1995-10-02 Immunolytics Inc Composition and method for treating benign prostatic hypertrophy
JPH0653675B2 (en) * 1990-09-13 1994-07-20 卓夫 辻 Skin wrinkle prevention and treatment agent

Also Published As

Publication number Publication date
DE4305460C2 (en) 1997-09-04
DE4305460A1 (en) 1994-08-25
WO1994019005A1 (en) 1994-09-01

Similar Documents

Publication Publication Date Title
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU6194094A (en) Sweetener, process for the preparation thereof and the use thereof
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUT72308A (en) Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation
AU4867697A (en) Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
AU6845994A (en) Solid protector against uv, process for its preparation and use thereof
AU1166895A (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-onederivatives, process for their preparation and the pharmaceutical compositions containing them
AU3892593A (en) Composition for therapeutic or diagnostic use, process for its preparation and its use
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
AU4278593A (en) Antimicrobial compositions, process for preparing the same and use
AU3681689A (en) C-terminus amidation enzyme composition, process for its preparation and its use
AU1441195A (en) Phenylmethyl hexanamides, and the use thereof
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU4601493A (en) Hydroxyalkylchitosan salt, production process thereof and cosmetic composition containing the same
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
AU7675198A (en) Sucralfate-containing composition and process for the preparation thereof
AU1251295A (en) Substituted benzimidazole, processes for its preparation and its pharmaceutical use
AU638082B2 (en) Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms
AU9139591A (en) Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof
AU3218195A (en) Alpha-d-pentofuranoside derivatives, process for preparing the same and their use